Patents by Inventor Matthew HELM

Matthew HELM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS AS UBIQUITIN SPECIFIC PROTEASE 7 INHIBITORS
    Publication number: 20250122223
    Abstract: The present invention concerns inhibitors of ubiquitin specific protease 7 (USP7), and methods of use thereof.
    Type: Application
    Filed: January 20, 2023
    Publication date: April 17, 2025
    Inventors: Frank BURKAMP, Adam Piotr TREDER, Colin O'DOWD, Lauren Emma PROCTOR, James Samuel Shane ROUNTREE, Matthew HELM, Aaron CRANSTON
  • Piperidine derivatives as inhibitors of ubiquitin specific protease 7
    Patent number: 10766903
    Abstract: The present invention concerns the identification of inhibitors of ubiquitin specific protease 7 (USP7), and methods of use thereof.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: September 8, 2020
    Assignee: ALMAC DISCOVERY LIMITED
    Inventors: Colin O'Dowd, Tim Harrison, Peter Hewitt, Shane Rountree, Miel Hugues, Frank Burkamp, Linda Duncan Jordan, Matthew Helm, Fabio Broccatelli, James John Crawford, Lewis Gazzard, Ingrid Wertz, Wendy Lee
  • PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7
    Publication number: 20190256518
    Abstract: The present invention concerns the identification of inhibitors of ubiquitin specific protease 7 (USP7), and methods of use thereof.
    Type: Application
    Filed: October 20, 2017
    Publication date: August 22, 2019
    Inventors: Colin O'DOWD, Tim HARRISON, Peter HEWITT, Shane ROUNTREE, Miel HUGUES, Frank BURKAMP, Linda Duncan JORDAN, Matthew HELM, Fabio BROCCATELLI, James John CRAWFORD, Lewis GAZZARD, Ingrid WERTZ, Wendy LEE